Coping Strategy and Anxiety Evolution in Multiple Sclerosis Patients Initiating Interferon-Beta Treatment

Publisher： Karger

E-ISSN： 1421-9913|62|2|79-85

ISSN： 0014-3022

Source： European Neurology, Vol.62, Iss.2, 2009-06, pp. : 79-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study

By  

European Neurology, Vol. 77, Iss. 1-2, 2016-12 ,pp. : 47-55

Karger

Access to resources Recommend Favorite

The Treatment of Multiple Sclerosis with Beta-Interferon

By  

Neuroepidemiology, Vol. 31, Iss. 3, 2008-08 ,pp. : 157-158

Karger

Access to resources Recommend Favorite

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 4, 2011-03 ,pp. : 231-232

Karger

Access to resources Recommend Favorite

Effect of Interferon-beta-1b on Cognitive Functions in Multiple Sclerosis

By  

European Neurology, Vol. 47, Iss. 1, 2002-01 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in Iran

By  

European Neurology, Vol. 52, Iss. 4, 2004-12 ,pp. : 202-206

Karger

Access to resources Recommend Favorite